Targeting mutation sites in the omicron variant of SARS-CoV-2 as potential therapeutic strategy against COVID-19 by antiretroviral drugs

Targeting mutation sites in the omicron variant of SARS-CoV-2 as potential therapeutic strategy against COVID-19 by antiretroviral drugs

The multiple mutation of the spike (S) protein of the Omicron SARS-CoV-2 variant is a major concern, as it has been implicated in the severity of COVID-19 and its complications. These mutations have been attributed to COVID-19-infected immune-compromised individuals, with HIV patients being suspecte...

Full description

Saved in:
Bibliographic Details
Main Authors: Ochuko L. Erukainure, Aliyu Muhammad, Rahul Ravichandran, Musa M. Abarshi, Sanusi B. Katsayal, Murtala B. Abubakar, Ya'qub U. Abiodun, Olubunmi Atolani, Robert Preissner, Priyanka Banerjee
Format: Article
Language:English
Published: Elsevier 2024-12-01
Series:Toxicology Reports
Subjects:
Antiretroviral
COVID-19
Omicron
And SARS-CoV-2
Online Access:http://www.sciencedirect.com/science/article/pii/S2214750024002087
Tags: Add Tag
No Tags, Be the first to tag this record!

Internet

http://www.sciencedirect.com/science/article/pii/S2214750024002087

Similar Items